Findings reveal an Achilles heel on the virus for AIDS vaccine researchers to exploit.

Monogram Biosciences, Inc. (Nasdaq:MGRM) today announced that additional EGFR/HER assays have been successfully tested in sets of fixed human tumors and are now available for use in drug development programs.

Monogram Biosciences, Inc. (Nasdaq:MGRM) announced today that William D. Young, Chairman and CEO, is scheduled to present a corporate overview at the Lazard Fifth Annual Healthcare Conference on Tuesday, November 18, 2008 at 4:10 p.m. (Eastern Time) at the St. Regis Hotel in New York City.

SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc.

SOUTH SAN FRANCISCO, Oct. 22 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that Monogram scientists have made presentations related to its expanding set of VeraTag assays at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Geneva, Switzerland.